JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Dairy Science Vol. 74 No. 12 4413-4424
© 1991 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daley, M. J.
Right arrow Articles by Hayes, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daley, M. J.
Right arrow Articles by Hayes, P. W.

Staphylococcus aureus Mastitis: Pathogenesis and Treatment with Bovine Interleukin-1ß and Interleukin-2

Michael J. Daley 1, Patricia A. Coyle 1, Thomas J. Williams 1, Gary Furda 1, Ruth Dougherty 1, and Phillip W. Hayes 1

1 Agricultural Research Division, American Cyanamid Co., Princeton, NJ 08543-0400

Polymorphonuclear leukocytes play a central role in the pathogenesis of bovine mastitis. Intramammary challenge with Staphylococcus aureus was shown to induce both quantitative and qualitative changes in mammary gland polymorphonuclear leukocytes. Intramammary infusion of recombinant bovine interleukin-1ß and interleukin-2 elicited a similar cellular response. Staphylococcus aureus, interleukin-1ß, and interleukin-2 all increased the number of somatic cells after intramammary infusion and activated the inducible superoxide production in milk polymorphonuclear leukocytes. Interleukin-2 also activated phagocytosis of these cells, and their activation was maintained for 3 to 5 d after intramammary administration. Inter-leukin-1ß and interleukin-2 were moderately effective in the therapy of experimental S. aureus mastitis. Approximately 54% of the glands treated with interleukin-1ß responded to therapy by transiently clearing the milk of S. aureus, 30% of which relapsed, and a total of 38% of the treated glands remained cured. In contrast, 83% of glands treated with interleukin-1ß responded to therapy, but 50% of these quarters relapsed. A total of 42% of the quarters treated with interleukin-1ß remained cured. Homologous recombinant cytokines are effective immunomodulators that augment natural defensive mechanisms similar to the normal response to pathogens and may prove to be suitable alternatives to, or may be used in combination with, antibiotics as effective mastitis therapeutic agents.

Key Words: cytokines • therapy • mastitis

Submitted on August 30, 1990
Accepted on June 28, 1991




This article has been cited by other articles:


Home page
 J DAIRY SCIHome page
D. Petitclerc, K. Lauzon, A. Cochu, C. Ster, M. S. Diarra, and P. Lacasse
Efficacy of a Lactoferrin-Penicillin Combination to Treat {beta}-Lactam-Resistant Staphylococcus aureus Mastitis
J Dairy Sci, June 1, 2007; 90(6): 2778 - 2787.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Dairy Science Association ®.